RemeGen Co. Ltd. Class A
688331
Peringkat dalam Saham
#2473
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Harga Saham
$14.27
Kapitalisasi Pasar
$7.99B
Perubahan (1 hari)
1.44%
Perubahan (1 tahun)
7.54%
Negara
CN
Perdagangan RemeGen Co. Ltd. Class A (688331)
Kategori
Healthcare
Riwayat hasil dividen untuk RemeGen Co. Ltd. Class A (688331)
Hasil dividen (TTM) dari RemeGen Co. Ltd. Class A (simbol saham: 688331) per 2023-12-31: 0.05%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.10%
Rata-rata hasil dividen selama 5 tahun terakhir: 0.10%
Riwayat hasil dividen untuk RemeGen Co. Ltd. Class A (688331) dari 2018 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Mengubah |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2024 | 0.43% | 760.00% |
| 2023 | 0.05% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
| Perusahaan | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
